N-(3-Cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicity

Journal of General Virology

Volumn 91, Issue 11, 2010, Pages 2762-2772

  Singethan, K ^a   Hiltensperger, G ^a   Kendl, S ^a   Wohlfahrt, J ^a   Plattet, P ^b   Holzgrabe, U ^a   Schneider Schaulies, J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AS 48; ANTIVIRUS AGENT; N (3 CYANOPHENYL) 2 PHENYLACETAMIDE; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; BENZENEACETAMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BLOOD; BRAIN CELL; CANINE DISTEMPER MORBILLIVIRUS; CELL SPREADING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DOG; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; LYMPHOCYTE; MEASLES VIRUS; MEMBRANE FUSION; NIPAH VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TISSUE CULTURE; VIRUS INHIBITION; WILD TYPE; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; IC50; NERVE CELL; PHYSIOLOGY; TOXICITY; VIRUS ENTRY;

ANIMALS; ANTIVIRAL AGENTS; BENZENEACETAMIDES; CELL SURVIVAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DISTEMPER VIRUS, CANINE; DOGS; HUMANS; INHIBITORY CONCENTRATION 50; LYMPHOCYTES; MEASLES VIRUS; MEMBRANE FUSION; NEURONS; NIPAH VIRUS; VIRUS INTERNALIZATION;

CANINE DISTEMPER VIRUS; CANIS FAMILIARIS; MEASLES VIRUS; MORBILLIVIRUS; NIPAH VIRUS; PARAMYXOVIRIDAE;

EID: 78049391239     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.025650-0     Document Type: Article

References (53)

1. Appel, M. J. G., Gillespie, J. H. & Siegert, R. (1972). Canine distemper virus. Virol Monogr 11, 1-96.
2. Blixenkrone-Moller, M., Svansson, V., Have, P., Orvell, C., Appel, M., Pedersen, I. R., Dietz, H. H. & Henriksen, P. (1993). Studies on manifestations of canine distemper virus infection in an urban dog population. Vet Microbiol 37, 163-173. (Pubitemid 23327310)
3. Butler, D. (2004). Fatal fruit bat virus sparks epidemics in southern Asia. Nature 429, 7.
4. Chadha, M. S., Comer, J. A., Lowe, L., Rota, P. A., Rollin, P. E., Bellini, W. J., Ksiazek, T. G. & Mishra, A. (2006). Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 12, 235-240. (Pubitemid 43297090)
5. Chong, H. T., Kamarulzaman, A., Tan, C. T., Goh, K. J., Thayaparan, T., Kunjapan, S. R., Chew, N. K., Chua, K. B. & Lam, S. K. (2001). Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol 49, 810-813. (Pubitemid 32530252)
6. Chua, K. B. (2003). Nipah virus outbreak in Malaysia. J Clin Virol 26, 265-275.
7. Condack, C., Grivel, J. C., Devaux, P., Margolis, L. & Cattaneo, R. (2007). Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196, 541-549. (Pubitemid 47206100)
8. De Franceschi, L., Fattovich, G., Turrini, F., Ayi, K., Brugnara, C., Manzato, F., Noventa, F., Stanzial, A. M., Solero, P. & Corrocher, R. (2000). Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 31, 997-1004. (Pubitemid 30169949)
9. + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3, e178.
10. Dittmar, S., Harms, H., Runkler, N., Maisner, A., Kim, K. S. & Schneider-Schaulies, J. (2008). Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol 82, 11273-11282.
11. Doyle, J., Prussia, A., White, L. K., Sun, A., Liotta, D. C., Snyder, J. P., Compans, R. W. & Plemper, R. K. (2006). Two domains that control prefusion stability and transport competence of the measles virus fusion protein. J Virol 80, 1524-1536. (Pubitemid 43134108)
12. Duclos, P. & Ward, B. J. (1998). Measles vaccines: a review of adverse events. Drug Saf 19, 435-454.
13. Elia, G., Belloli, C., Cirone, F., Lucente, M. S., Caruso, M., Martella, V., Decaro, N., Buonavoglia, C. & Ormas, P. (2008). In vitro efficacy of ribavirin against canine distemper virus. Antiviral Res 77, 108-113.
14. Epand, R. M. (1986). Virus replication inhibitory peptide inhibits the conversion of phospholipid bilayers to the hexagonal phase. Biosci Rep 6, 647-653.
15. Erlenhoefer, C., Wurzer, W. J., Löffler, S., Schneider-Schaulies, S., ter Meulen, V. & Schneider-Schaulies, J. (2001). CD150 (SLAM) is a receptor for measles virus, but is not involved in viral contact-mediated proliferation inhibition. J Virol 75, 4499-4505.
16. Erlenhoefer, C., Duprex, W. P., Rima, B. K., ter Meulen, V. & Schneider-Schaulies, J. (2002). Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 83, 1431-1436.
17. Ferreira, C. S., Frenzke, M., Leonard, V. H., Welstead, G. G., Richardson, C. D. & Cattaneo, R. (2010). Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J Virol 84, 3033-3042.
18. Gemma, T., Watari, T., Akiyama, K., Miyashita, N., Shin, Y. S., Iwatsuki, K., Kai, C. & Mikami, T. (1996). Epidemiological observations on recent outbreaks of canine distemper in Tokyo area. J Vet Med Sci 58, 547-550.
19. 12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother 50, 1768-1772.
20. Graci, J. D. & Cameron, C. E. (2006). Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol 16, 37-48.
21. Gururangan, S., Stevens, R. F. & Morris, D. J. (1990). Ribavirin response in measles pneumonia. J Infect 20, 219-221.
22. Harder, T. C. & Osterhaus, A. D. (1997). Canine distemper virus - a morbillivirus in search of new hosts? Trends Microbiol 5, 120-124.
23. Hashimoto, K., Ono, N., Tatsuo, H., Minagawa, H., Takeda, M., Takeuchi, K. & Yanagi, Y. (2002). SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76, 6743-6749.
24. Honda, Y., Hosoya, M., Ishii, T., Shigeta, S. & Suzuki, H. (1994). Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters. Antimicrob Agents Chemother 38, 653-655.
25. Huffman, J. H., Sidwell, R. W., Khare, G. P., Witkowski, J. T., Allen, L. B. & Robins, R. K. (1973). In vitro effect of 1-β-D-ribofuranosyl-1,2, 4- triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother 3, 235-241.
26. Ishii, T., Hosoya, M., Mori, S., Shigeta, S. & Suzuki, H. (1996). Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother 40, 241-243.
27. Ludlow, M., Allen, I. & Schneider-Schaulies, J. (2009). Systemic spread of measles virus: overcoming the epithelial and endothelial barriers. Thromb Haemost 102, 1050-1056.
28. Meanwell, N. A. & Krystal, M. (2000). Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents. Drug Discov Today 5, 241-252.
29. Moll, M., Pfeuffer, J., Klenk, H.-D., Niewiesk, S. & Maisner, A. (2004). Polarized glycoprotein targeting affects the spread of measles virus in vitro and in vivo. J Gen Virol 85, 1019-1027.
30. Murray, K., Selleck, P., Hooper, P., Hyatt, A., Gould, A., Gleeson, L., Westbury, H., Hiley, L., Selvey, L. & other authors (1995). A morbillivirus that caused fatal disease in horses and humans. Science 268, 94-97.
31. Nanan, R., Chittka, B., Hadam, M. & Kreth, H. W. (1999). Measles virus infection causes transient depletion of activated T cells from peripheral circulation. J Clin Virol 12, 201-210.
32. Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S. & Lee, B. (2005). EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436, 401-405.
33. Niedermeier, S., Singethan, K., Rohrer, S. G., Matz, M., Kossner, M., Diederich, S., Maisner, A., Schmitz, J., Hiltensperger, G. & other authors (2009). A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion. J Med Chem 52, 4257-4265.
34. Pfeuffer, J., Püschel, K., ter Meulen, V., Schneider-Schaulies, J. & Niewiesk, S. (2003). Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus). J Virol 77, 150-158.
35. Plattet, P., Zweifel, C., Wiederkehr, C., Belloy, L., Cherpillod, P., Zurbriggen, A. & Wittek, R. (2004). Recovery of a persistent canine distemper virus expressing the enhanced green fluorescent protein from cloned cDNA. Virus Res 101, 147-153.
36. Plattet, P., Rivals, J. P., Zuber, B., Brunner, J. M., Zurbriggen, A. & Wittek, R. (2005). The fusion protein of wild-type canine distemper virus is a major determinant of persistent infection. Virology 337, 312-326.
37. Plattet, P., Langedijk, J. P., Zipperle, L., Vandevelde, M., Orvell, C. & Zurbriggen, A. (2009). Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity. Biochemistry 48, 9112-9121.
38. Plemper, R. K., Erlandson, K. J., Lakdawala, A. S., Sun, A., Prussia, A., Boonsombat, J., Aki-Sener, E., Yalcin, I., Yildiz, I. & other authors (2004). A target site for template-based design of measles virus entry inhibitors. Proc Natl Acad Sci U S A 101, 5628-5633.
39. Plemper, R. K., Doyle, J., Sun, A., Prussia, A., Cheng, L. T., Rota, P. A., Liotta, D. C., Snyder, J. P. & Compans, R. W. (2005). Design of a small-molecule entry inhibitor with activity against primary measles virus strains. Antimicrob Agents Chemother 49, 3755-3761.
40. Richardson, C. D. & Choppin, P. W. (1983). Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology 131, 518-532.
41. Schneider-Schaulies, S. & Schneider-Schaulies, J. (2009). Measles virus-induced immunosuppression. Curr Top Microbiol Immunol 330, 243-269.
42. Summers, B. A. & Appel, M. J. G. (1994). Aspects of canine distemper virus and measles virus encephalomyelitis. Neuropathol Appl Neurobiol 20, 525-534.
43. Sun, A., Prussia, A., Zhan, W., Murray, E. E., Doyle, J., Cheng, L. T., Yoon, J. J., Radchenko, E. V., Palyulin, V. A. & other authors (2006). Nonpeptide inhibitors of measles virus entry. J Med Chem 49, 5080-5092.
44. Tan, C. T., Goh, K. J., Wong, K. T., Sarji, S. A., Chua, K. B., Chew, N. K., Murugasu, P., Loh, Y. L., Chong, H. T. & other authors (2002). Relapsed and late-onset Nipah encephalitis. Ann Neurol 51, 703-708.
45. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. (2000). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897.
46. Vandevelde, M. & Zurbriggen, A. (1995). The neurobiology of canine distemper virus infection. Vet Microbiol 44, 271-280.
47. Vandevelde, M. & Zurbriggen, A. (2005). Demyelination in canine distemper virus infection: a review. Acta Neuropathol 109, 56-68.
48. von Messling, V., Springfeld, C., Devaux, P. & Cattaneo, R. (2003). A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77, 12579-12591.
49. Weissbrich, B., Schneider-Schaulies, J. & ter Meulen, V. (2003). Measles and its neurological complications. Edited by A. Nath & J. R. Berger. New York: Marcel Dekker.
50. Wong, K. T., Shieh, W. J., Kumar, S., Norain, K., Abdullah, W., Guarner, J., Goldsmith, C. S., Chua, K. B., Lam, S. K. & other authors (2002). Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161, 2153-2167.
51. Wyss-Fluehmann, G., Zurbriggen, A., Vandevelde, M. & Plattet, P. (2010). Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein. Acta Neuropathol 119, 617-630.
52. Zurbriggen, A., Vandevelde, M., Beranek, C. F. & Steck, A. (1984). Morphological and immunocytochemical characterisation of mixed glial cell cultures derived from neonatal canine brain. Res Vet Sci 36, 270-275.
53. Zurbriggen, A., Graber, H. U., Wagner, A. & Vandevelde, M. (1995). Canine distemper virus persistence in the nervous system is associated with noncytolytic selective virus spread. J Virol 69, 1678-1686.